Anne Clem Whitaker Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anne Clem Whitaker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anne Clem Whitaker. Anne Clem Whitaker is Director in CALADRIUS BIOSCIENCES, INC. ($NBS) and Director in CREE INC ($CREE) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and EVP, Company Group Chairman in Valeant Pharmaceuticals International, Inc. ($BVF) and President and CEO in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Mallinckrodt plc ($MNK).
Latest Insider Trading Transactions of Anne Clem Whitaker
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BVF, NBS, CREE, SNTA, MNK
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Whitaker Anne Clem | Director | Grant | A | 0.00 | 37,735 | 0 | 117,205 | 79.5 K to 117.2 K (+47.48 %) |
Nov 10 2020 | MNK | Mallinckrodt plc | Whitaker Anne Clem | Director | Sell | S | 0.13 | 21,087 | 2,741 | 0 | 21.1 K to 0 (-100.00 %) |
Nov 06 2020 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Option Exercise | M | 57.36 | 4,000 | 229,440 | 0 | |
Nov 06 2020 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Sell | S | 67.87 | 25,248 | 1,713,582 | 11,274 | 36.5 K to 11.3 K (-69.13 %) |
Nov 06 2020 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Sell | S | 68.35 | 4,000 | 273,400 | 36,522 | 40.5 K to 36.5 K (-9.87 %) |
Nov 06 2020 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Buy | M | 57.36 | 4,000 | 229,440 | 40,522 | 36.5 K to 40.5 K (+10.95 %) |
Nov 03 2020 | NBS | CALADRIUS BIOSCIEN ... | Whitaker Anne Clem | Director | Grant | A | 1.51 | 79,470 | 120,000 | 79,470 | 0 to 79.5 K |
Sep 03 2020 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Grant | A | 0.00 | 2,652 | 0 | 36,522 | 33.9 K to 36.5 K (+7.83 %) |
Sep 03 2020 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Grant | A | 0.00 | 2,652 | 0 | 36,522 | 33.9 K to 36.5 K (+7.83 %) |
May 15 2020 | MNK | Mallinckrodt plc | Whitaker Anne Clem | Director | Payment of Exercise | F | 2.96 | 8,729 | 25,838 | 21,087 | 29.8 K to 21.1 K (-29.28 %) |
May 15 2020 | MNK | Mallinckrodt plc | Whitaker Anne Clem | Director | Payment of Exercise | F | 2.96 | 8,729 | 25,838 | 21,087 | 29.8 K to 21.1 K (-29.28 %) |
Sep 04 2019 | CREE | CREE, INC. | Whitaker Anne Clem | Director | Grant | A | 0.00 | 3,217 | 0 | 33,870 | 30.7 K to 33.9 K (+10.49 %) |
May 17 2019 | MNK | Mallinckrodt plc | Whitaker Anne Clem | Director | Grant | A | 0.00 | 19,396 | 0 | 29,816 | 10.4 K to 29.8 K (+186.14 %) |
May 17 2019 | MNK | Mallinckrodt plc | Whitaker Anne Clem | Director | Payment of Exercise | F | 15.21 | 8,527 | 129,696 | 10,420 | 18.9 K to 10.4 K (-45.00 %) |
Sep 05 2018 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 3,566 | 0 | 30,653 | 27.1 K to 30.7 K (+13.16 %) |
May 18 2018 | MNK | Mallinckrodt plc | Whitaker Anne Clem | Director | Grant | A | 0.00 | 18,947 | 0 | 18,947 | 0 to 18.9 K |
Sep 06 2017 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 7,033 | 0 | 27,087 | 20.1 K to 27.1 K (+35.07 %) |
Dec 20 2016 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | EVP, Company Group ... | Payment of Exercise | F | 23.54 | 834 | 19,632 | 158,544 | 159.4 K to 158.5 K (-0.52 %) |
Dec 07 2016 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | EVP, Company Group ... | Payment of Exercise | F | 18.00 | 6,505 | 117,090 | 158,885 | 165.4 K to 158.9 K (-3.93 %) |
Sep 06 2016 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 6,429 | 0 | 20,054 | 13.6 K to 20.1 K (+47.19 %) |
May 16 2016 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | EVP, Company Group ... | Grant | A | 0.00 | 37,935 | 0 | 165,390 | 127.5 K to 165.4 K (+29.76 %) |
Feb 18 2016 | CREE | CREE INC | Whitaker Anne Clem | Director | Sell | S | 30.00 | 623 | 18,690 | 13,625 | 14.2 K to 13.6 K (-4.37 %) |
Sep 03 2015 | CREE | CREE INC | Whitaker Anne Clem | Director | Sell | S | 26.74 | 1,994 | 53,325 | 14,248 | 16.2 K to 14.2 K (-12.28 %) |
Sep 03 2015 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 6,674 | 0 | 16,242 | 9.6 K to 16.2 K (+69.75 %) |
Jul 22 2015 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | EVP, Company Group ... | Grant | A | 0.00 | 7,500 | 0 | 127,455 | 120 K to 127.5 K (+6.25 %) |
Jun 24 2015 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | EVP, Company Group ... | Grant | A | 0.00 | 112,455 | 0 | 119,955 | 7.5 K to 120 K (+1,499.40 %) |
May 27 2015 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | Director | Buy | P | 234.00 | 2,500 | 585,000 | 7,500 | 5 K to 7.5 K (+50.00 %) |
May 27 2015 | BVF | Valeant Pharmaceut ... | Whitaker Anne Clem | Director | Buy | P | 235.00 | 5,000 | 1,175,000 | 5,000 | 0 to 5 K |
Mar 04 2015 | SNTA | SYNTA PHARMACEUTIC ... | Whitaker Anne Clem | President and CEO | Option Exercise | A | 2.38 | 100,000 | 238,000 | 100,000 | |
Jan 23 2015 | CREE | CREE INC | Whitaker Anne Clem | Director | Sell | S | 35.09 | 624 | 21,894 | 9,568 | 10.2 K to 9.6 K (-6.12 %) |
Jan 23 2015 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 33.87 | 553 | 18,730 | 10,192 | 9.6 K to 10.2 K (+5.74 %) |
Oct 24 2014 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 4,244 | 0 | 8,952 | 4.7 K to 9 K (+90.14 %) |
Sep 03 2014 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 4,244 | 0 | 8,952 | 4.7 K to 9 K (+90.14 %) |
Aug 15 2014 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 44.81 | 278 | 12,457 | 4,708 | 4.4 K to 4.7 K (+6.28 %) |
Apr 25 2014 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 51.01 | 245 | 12,497 | 4,430 | 4.2 K to 4.4 K (+5.85 %) |
Jan 24 2014 | CREE | CREE INC | Whitaker Anne Clem | Director | Buy | J | 67.30 | 185 | 12,451 | 4,185 | 4 K to 4.2 K (+4.63 %) |
Dec 04 2013 | CREE | CREE INC | Whitaker Anne Clem | Director | Option Exercise | A | 57.36 | 4,000 | 229,440 | 4,000 | |
Dec 04 2013 | CREE | CREE INC | Whitaker Anne Clem | Director | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Page: 1